There was a time when medical science believed it was invincible
Michael C. Sherrin
There was a time when medical science believed it was invincible. With the
development of antibiotics, once life-threatening bacteria like gonorrhea, syphilis,
tuberculosis, and scarlet fever became treatable ailments. In 1979, the World Health
Organization declared success in ridding the world of smallpox, showing the power of
vaccinations. Beliefs started circulating that human illness would be a thing of the past.
Modern medicine could develop a cure or vaccine for any microscopic foe.
Unfortunately, that peaceful state of mind ended shortly. The onslaught of HIV in the
early 1980’s showed that Mother Nature was not without new weapons. Ebola surfaced
in Africa killing an unprecedented 97% of its victims. With the incredible hazard these
viruses pose, pubic attention has been ignoring a growing threat happening world wide,
and even in our own hospitals. The miracle of antibiotics is creating a looming fallout in
the medical world where once fatal, now curable diseases, are becoming fatal once again.
For a variety of reasons, bacteria are developing resistances to antibiotics and are slowly
To begin, bacterial infections are different than viral infections. Bacteria are
much larger than viruses, able to been seen under a normal microscope. Everything from
the green mold on bread to making cheese is caused by different bacteria. Certain
bacteria cause infections in humans. Unlike viruses, bacteria can be cured. Viruses are
twenty to one hundred times smaller than bacteria and can only be seen using special,
electron microscopes. Viruses like the common cold and the flu cannot be cured once
Michael C. Sherrin
you get sick, although vaccines can be administered in order to prevent a person from
Bacteria gain a resistance to antibiotics through evolution. When a person
infected with a bacteria is given antibiotics, those antibiotics kill most, if not all of the
bacteria. If the antibiotics do not kill all the bacteria, that bacteria might have evolved a
defense against the antibiotic, a trait it reproduces in its millions of offspring; the way
tuberculosis evolves. Another way bacteria become drug resistant thrives inside areas of
high infestation like hospitals. A person in the hospital being treated with one bacterium
may contract another bacteria from another patient. The new bacteria trade DNA with
the other bacteria, trading a genetic immunity to the antibiotics. Gonorrhea became
resistant to penicillin in this manner. Because this is a part of evolution, different strains
of different bacteria will exist. A person may contract a strain of gonorrhea resistant to
penicillin while another may contract the strain that is not resistant. The survival of the
fittest threat is that the more drug-resistant strains will continue to spread.
Numerous factors have contributed to the development of drug resistant bacteria.
The largest factor has arguably been the overuse of antibiotics. Because of the public
view that modern medicine had defeated its foes, people demanded results when they
were sick. Doctors prescribed antibiotics in cases where mild infections were present or
viruses were the cause, meaning the antibiotics wouldn’t even work. Healthcare
organizations outline guidelines for the administration of these medicines, but the Center
for Disease Control reported in 1999 that 60% of hospital prescriptions for vancomycin
did not follow guidelines. A 2004 study in Washington state found that 20% of adults
Michael C. Sherrin
asked for antibiotics before recommended by their heath care provider. Michael Blum,
M.D. of the Food and Drug Administration says “There was complacency in the 1980s.
The perception was that we had licked the bacterial infection problem. Drug companies
weren't working on new agents. They were concentrating on other areas, such as viral
infections. In the meantime, resistance increased to a number of commonly used
antibiotics, possibly related to overuse of antibiotics. In the 1990s, we've come to a point
for certain infections that we don't have agents available.” Furthermore, patients who do
not complete their dosage risk spreading drug-resistant strains of bacteria. The more
resistant bacteria may survive until the last few days of your medication, which is why
doctors say patients need to complete their full dosage, regardless of whether they feel
Hospitals have helped spread drug-resistant strains, most often due to patients
contracting new infections while in the hospital. The Nation Institute of Allergy and
Infectious Diseases, a division of the U.S. Department of Health and Human Services
reported in April of 2004 that two million patients got an infection while in a United
States hospital. 90,000 of those patients died as a result of those infections, up from
13,300 deaths in 1992. Over 70% of the bacteria contracted during hospital stays are
resistant to at least one antibiotic used to combat the infection.
The last major contributor to drug-resistant bacteria is found in livestock.
Caretakers and farmers give their livestock numerous antibiotics even when the animals
are not sick in order to prevent illness in the future. Sometimes lower doses are fed to the
animals through their food. As a result, animals may have bacteria in them without
Michael C. Sherrin
symptoms. The National Antimicrobial Resistance Monitoring System found that 11,477
people contracted the bacteria Campylobacter
from chicken treated with the antibiotic
. Even in people, the bacteria were resistant to the antibiotic.
Health organizations are actively trying to prevent further antibiotic resistance.
Though officials admit resistance is inevitable, slowing the spread of resistant strains and
developing more drugs will help. The CDC and other organizations are advising health
care providers about recommended treatments and the guidelines with which to use them.
Emphasis is put on keeping “last resort drugs” safe from resistance, though vancomycin,
considered the “last resort” for many infections, is being found ineffective against a select
few bacterial strains. Nevertheless, progress is being made slowly, mostly by ensuring
that patients take their medications correctly. Efforts are being made to monitor drug-
resistant stains in hospitals and provide improved sanitation in developing nations. The
fear is still there as education remains limited regarding these “super bugs.”
Globalization has helped the spread of drug-resistant bacteria; drug-resistant gonorrhea
came to America through soldiers who contracted the bacteria from prostitutes in
Southeast Asia during the 1970’s. Education, moderation, and awareness can stave off
further resistance. But solutions are far from found.
• “Rise of Antibiotic-Resistant Infections.” Lewis, Dr. Ricki. U.S. Food and Drug Administration.
September 1995. http://www.fda.gov/fdac/features/795_antibio.html
Michael C. Sherrin
• “Antibiotic Resistance.” U.S. Food and Drug Administration.
• “Careful Use of Antibiotics.” Washington State Department of Health. 10/12/2004.
• “Problem of Antibiotic Resistance.” National Institute of Allergy and Infectious Diseases. April
• “A Growing Threat to Public Health.” Center for Disease Control. June 1999.
• “From Down On The Chicken Farm.” Bren, Linda. FDA Consumer magazine. January-February
• “Guidelines and Recommendations.” Center for Disease Control. June 25th, 2004.
PROCESS RESOURCES, INC. PRI 10440 CORPORATE DRIVE • SUGAR LAND, TEXAS 77478 281-240-0955 • FAX 281-240-8025 e-mail: [email protected] PROCESS RESOURCES, INC. AND SUBSIDIARIES STANDARD TERMS AND CONDITIONS OF SALE The equipment, software, materials and services (collectively, the “Equipment”) which are described on the face hereof shall
Neuartige Migränetherapie durch Kinesio Tapinghttp://www.aeksh.de/shae_alt/200205/h025056a.html Kammer-Info aktuell Neuartige Migränetherapie durch Kinesio Taping Dieter Sielmann Zusammenfassung 15 Patienten wurden erstmalig durch Kinesio-Taping-Methode erfolgreich von ihrer Migräne befreit. Kinesio-Taping ist aufgrund ihres Tapematerials und ihrer Anwendungstechnik eine neuartigeTa